文献速递类风湿关节炎

难治性类风湿关节炎: contributing factors 与疾病负担

Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该研究纳入连续就诊的类风湿关节炎(RA)患者,按 EULAR 定义分为难治性(D2T)组与非 D2T 对照组,评估 D2T 的相关因素与疾病负担。RA 起病时较低社会经济地位是发生 D2T 的独立危险因素(OR 1.97,95%CI 1.08-3.61)。多种因素与 D2T 独立相关,D2T 患者疾病负担显著更高,聚类分析识别出 3 个 D2T 亚组。

要点

  • RA 起病时较低社会经济地位与日后发生 D2T RA 独立相关。
  • 药物选择受限、患者与医生治疗意愿不一致、合并纤维肌痛及应对能力较差在 D2T 中更常见。
  • D2T RA 疾病负担显著更高且异质,可分 3 个亚组。

核心结论

  • D2T RA 涉及多种相关因素、疾病负担高且具有异质性,日常实践应识别这些因素以个体化调整治疗策略。

研究设计与样本

  • 连续纳入 RA 患者,按 EULAR 定义分为 D2T 组与非 D2T 对照组,用 logistic 回归分析起病时危险因素及与 D2T 独立相关的因素,并用聚类分析探索 D2T 亚组。

主要发现

  • RA 起病时较低社会经济地位是发生 D2T RA 的独立危险因素,OR 1.97(95%CI 1.08-3.61)。
  • 因不良事件导致药物选择受限在 D2T 与非 D2T 中分别为 94% 与 57%,因合并症受限分别为 69% 与 37%。
  • 患者与风湿科医生在是否强化治疗上的意愿不一致分别为 37% 与 6%,合并纤维肌痛分别为 38% 与 9%,D2T 患者应对能力更差。
  • D2T RA 患者疾病负担显著更高,聚类分析识别出 3 个亚组:非依从且不满意的患者、疼痛综合征与肥胖患者、最接近真正难治性 RA 概念的患者。

临床怎么用

  • 日常实践中应识别社会经济地位、药物选择受限、治疗意愿不一致、合并纤维肌痛与应对能力等因素,以个体化制定 D2T RA 治疗策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Treatment of difficult-to-treat (D2T) RA patients is generally based on trial-and-error and can be challenging due to a myriad of contributing factors. We aimed to identify risk factors at RA onset, contributing factors and the burden of disease. METHODS: Consecutive RA patients were enrolled and categorized as D2T, according to the EULAR definition, or not (controls). Factors potentially contributing to D2T RA and burden of disease were assessed. Risk factors at RA onset and factors independently associated with D2T RA were identified by logistic regression. D2T RA subgroups were explored by cluster analysis. RESULTS: Fifty-two RA patients were classified as D2T and 100 as non-D2T. Lower socioeconomic status at RA onset was found as an independent risk factor for developing D2T RA [odds ratio (OR) 1.97 (95%CI 1.08-3.61)]. Several contributing factors were independently associated with D2T RA, occurring more frequently in D2T than in non-D2T patients: limited drug options because of adverse events (94% vs 57%) or comorbidities (69% vs 37%), mismatch in patient's and rheumatologist's wish to intensify treatment (37% vs 6%), concomitant fibromyalgia (38% vs 9%) and poorer coping (worse levels). Burden of disease was significantly higher in D2T RA patients. Three subgroups of D2T RA patients were identified: (i) 'non-adherent dissatisfied patients'; (ii) patients with 'pain syndromes and obesity'; (iii) patients closest to the concept of 'true refractory RA'. CONCLUSIONS: This comprehensive study on D2T RA shows multiple contributing factors, a high burden of disease and the heterogeneity of D2T RA. These findings suggest that these factors should be identified in daily practice in order to tailor therapeutic strategies further to the individual patient.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Roodenrijs NMT, van der Goes MC, Welsing PMJ, et al. Difficult-to-treat rheumatoid arthritis: contributing factors and burden of disease. Rheumatology (Oxford). 2021. PMID: 33331946. doi:10.1093/rheumatology/keaa860

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。